Clinical Trial

The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease

Study acronym: ICoRe
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Chronic obstructive pulmonary disease (COPD) is a treatable but debilitating medical condition associated with persistent symptoms and chronic airflow obstruction. Despite the availability of multiple therapeutic options, COPD is the third leading cause of death worldwide and has a substantial socioeconomic impact. The present real life study is aimed at describing the clinical and functional characteristics, treatment patterns, impact of exacerbations and comorbidities and their association with mortality in a large cohort of Italian patients with COPD.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-21.
Trial Details
NCT Number NCT06652776
Lead Sponsor University of Milan
Collaborators: University of Genova, University of Pavia, Azienda Ospedaliera Universitaria Integrata Verona, University Magna Graecia, University of Rome Tor Vergata, Università degli Studi di Sassari, University of Palermo, University of Turin, Italy, University Hospital Verona, Italy, University Hospital of Ferrara, Societa Italiana di Pneumologia, Italian Association of Hospital Pneumologists
Conditions COPD, COPD Exacerbation Acute, Comorbid Chronic Lung Disease on Heart Failure, Mortality, Cardiovascular Diseases, Cardiovascular Events, COPD Prevalance
Enrollment 10,000 participants
Start Date 2024-09-30
Primary Completion 2035-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-04